Am. J. Respir. Crit. Care Med., Volume 157, Number 6, June 1998, 1951-1958

Bronchial Artery Embolization for the Treatment of Hemoptysis in Patients with Cystic Fibrosis

GEORGE M. BRINSON, PEADAR G. NOONE, MATTHEW A. MAURO, MICHAEL R. KNOWLES, JAMES R. YANKASKAS, JEET S. SANDHU, and PAUL F. JAQUES

Division of Pulmonary and Critical Care Medicine and the UNC-CF Center, Department of Medicine, University of North Carolina School of Medicine, and Department of Radiology, University of North Carolina School of Medicine, Chapel Hill, North Carolina

Hemoptysis is common in patients with cystic fibrosis (CF). Bleeding may vary in severity, ranging from minor blood-streaking of sputum to expectoration of significant quantities of blood. Major hemoptysis, defined as bleeding greater than 240 ml/24 h, represents a medical emergency. Bronchial artery embolization (BAE) is one of the treatment options for hemoptysis. We reviewed the 10-yr experience at the University of North Carolina Hospitals in the treatment of hemoptysis by BAE. Eighteen patients with CF were hospitalized on 29 occasions and underwent 36 BAE procedures for the control of hemoptysis. Most patients (n = 11) had very severe lung disease (FEV₁ < 35%) with a high incidence (n = 9, 50%) of multi-drug-resistant bacteria. Fifteen patients (n = 33 procedures) were followed for a mean of ~ 22 mo after BAE. The overall efficacy of BAE for initial control of hemoptysis was 75% (n = 22) after one session, 89% (n = 26) after two sessions, and 93% (n = 27) after three sessions. The overall recurrence rate per episode was 46% (12/26 presentations in four patients) with a mean time for recurrence of ~ 12 mo. There was a high incidence (75%) of bleeding from nonbronchial systemic collateral vessels among patients (n = 7) who had undergone a previous BAE. There were two deaths associated with massive hemoptysis despite BAE. Three patients had transient neurologic deficits during BAE. We concluded that BAE is a relatively safe and effective means of treating significant hemoptysis in patients with CF.

This article has been cited by other articles:

				A. Sukkar, J. Jenkins, J. Sanchez, and E. M. Wagner Inhibition of CXCR2 attenuates bronchial angiogenesis in the ischemic rat lung J Appl Physiol, May 1, 2008; 104(5): 1470 - 1475. [Abstract] [Full Text] [PDF]

				T. M. Kremer, R. G. Zwerdling, P. H. Michelson, and B. P. O'Sullivan Intensive Care Management of the Patient With Cystic Fibrosis J Intensive Care Med, May 1, 2008; 23(3): 159 - 177. [Abstract] [PDF]

				E. M. Wagner, J. Sanchez, J. Y. McClintock, J. Jenkins, and A. Moldobaeva Inflammation and ischemia-induced lung angiogenesis Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L351 - L357. [Abstract] [Full Text] [PDF]

				J. Sanchez, A. Moldobaeva, J. McClintock, J. Jenkins, and E. Wagner The role of CXCR2 in systemic neovascularization of the mouse lung J Appl Physiol, August 1, 2007; 103(2): 594 - 599. [Abstract] [Full Text] [PDF]

				J. Y. McClintock and E. M. Wagner Role of IL-6 in systemic angiogenesis of the lung J Appl Physiol, September 1, 2005; 99(3): 861 - 866. [Abstract] [Full Text] [PDF]

				J L Lordan, A Gascoigne, and P A Corris The pulmonary physician in critical care * Illustrative case 7: Assessment and management of massive haemoptysis Thorax, September 1, 2003; 58(9): 814 - 819. [Full Text] [PDF]

				M. P. Revel, L. S. Fournier, A. S. Hennebicque, C. A. Cuenod, G. Meyer, P. Reynaud, and G. Frija Can CT Replace Bronchoscopy in the Detection of the Site and Cause of Bleeding in Patients with Large or Massive Hemoptysis? Am. J. Roentgenol., November 1, 2002; 179(5): 1217 - 1224. [Abstract] [Full Text] [PDF]

				J. Barben, D. Robertson, A. Olinsky, and M. Ditchfield Bronchial Artery Embolization for Hemoptysis in Young Patients with Cystic Fibrosis Radiology, July 1, 2002; 224(1): 124 - 130. [Abstract] [Full Text]

				P. Bhattacharyya, A. Dutta, A. N. Samanta, and S. R. Chowdhury New Procedure: Bronchoscopic Endobronchial Sealing* : A New Mode of Managing Hemoptysis Chest, June 1, 2002; 121(6): 2066 - 2069. [Abstract] [Full Text] [PDF]

				M. Antonelli, F. Midulla, G. Tancredi, F. M. Salvatori, E. Bonci, G. Cimino, and I. Flaishman Bronchial Artery Embolization for the Management of Nonmassive Hemoptysis in Cystic Fibrosis Chest, March 1, 2002; 121(3): 796 - 801. [Abstract] [Full Text] [PDF]

				M. L. Wong, P. Szkup, and M. J. Hopley Percutaneous Embolotherapy for Life-Threatening Hemoptysis Chest, January 1, 2002; 121(1): 95 - 102. [Abstract] [Full Text] [PDF]

				E. I. Hsiao, C. M. Kirsch, F. T. Kagawa, J. H. Wehner, W. A. Jensen, and R. B. Baxter Utility of Fiberoptic Bronchoscopy Before Bronchial Artery Embolization for Massive Hemoptysis Am. J. Roentgenol., October 1, 2001; 177(4): 861 - 867. [Abstract] [Full Text] [PDF]

				H.K. Kaukuntla, K.M.A. Amer, D. Honeybourne, D.E. Stableforth, and J.F. Khalil-Marzouk Extrapleural Bronchial Artery Ligation for Life-Threatening Hemoptysis in Cystic Fibrosis: A Case Report Angiology, September 1, 2000; 51(9): 787 - 792. [Abstract] [PDF]